Current Status of Fertility Preservation Technology in Georgia and Analysis of Suitable Candidates

Doctor's Decision Logic: When Is It Suitable to Consider Fertility Preservation in Georgia

In a reproductive clinic, when a doctor determines whether a woman is suitable for fertility preservation, the core basis is ovarian reserve function, the legal environment, and personal fertility plans. As a destination for fertility preservation, Georgia's technical standards, legal inclusiveness, and cost-effectiveness are three core considerations. The technology itself is no longer a bottleneck; the key lies in "why preserve" and "what to preserve."

What Is the Core Technology: Vitrification and Laboratory Quality

Fertility preservation technology in Georgia is mature, with the core being vitrification, mainly applied to oocytes and embryos. The technological maturity is comparable to that of Europe and the United States, but laboratory quality is a variable.

• Oocyte Cryopreservation: Suitable for single women, requiring a larger number of eggs to ensure cumulative live birth rates.
• Embryo Cryopreservation: Suitable for women with a partner, or for freezing embryos after obtaining sperm from a sperm bank.
• Laboratory Standards: It is recommended to choose a laboratory with CAP or ISO certification, with transparent data, especially MII oocyte rate, survival rate, and recovery rate.

Suitable and Unsuitable Situations

Suitable Candidates:

• Single women under 38 years old with an AMH level above 1.2 ng/ml who wish to delay childbearing.
• Women who need to undergo chemotherapy or radiotherapy for malignant tumors and wish to preserve fertility.
• Women planning to have children after age 40 due to career planning or social factors.
• Families who legally accept embryo freezing and have clear legal agreements.

Unsuitable Candidates:

• Women with premature ovarian failure (AMH below 0.5 ng/ml, FSH above 15 IU/L) and very few follicles, where freezing has limited significance.
• Women with uncontrolled underlying diseases (e.g., unstable hypertension, diabetes) who cannot safely undergo ovarian stimulation treatment.
• Those who cannot accept the risk of unclear legal rights (especially in the case of embryo freezing).

Decision Differences by Age Group

Differences from Other Countries: Law, Process, and Cost

Georgia holds a unique position in the field of fertility preservation. Compared to the United States, the process is more streamlined and the price is more advantageous; compared to Spain, there are fewer legal restrictions on oocyte cryopreservation for single women.

• Legal Environment: Georgian law allows single women to freeze their eggs, but when it comes to embryo freezing, clear legal documents must be signed specifying the disposition of embryos in the event of death or loss of contact.
• Process Differences: Usually, one trip to Georgia is needed for the initial consultation and pre-stimulation checks, and a second trip for egg retrieval and freezing. Subsequent use requires planning 3-6 months in advance.
• Cost Advantage: The cost is about one-third to one-half of that in the United States, but additional costs such as round-trip airfare, accommodation, and translation services should be considered.

Actual Process and Timeline

From the initial consultation to the completion of cryopreservation, it generally takes 2-3 months.

1. Remote Initial Consultation: Submit AMH, FSH, antral follicle count, and infectious disease screening reports. A reproductive doctor evaluates ovarian reserve.
2. Legal Consultation: Clarify legal rights and sign informed consent and legal agreements.
3. Travel to Georgia for Ovarian Stimulation: Starting on day 2-4 of the menstrual cycle, lasting 10-14 days, with monitoring of follicle development and hormone levels.
4. Egg Retrieval Surgery: Performed under intravenous anesthesia, lasting about 20-30 minutes. Patients can be discharged 2-4 hours after observation.
5. Vitrification: An embryologist assesses oocyte maturity. Mature oocytes are frozen within 30 minutes. Embryo freezing is performed on day 5-6 after fertilization.
6. Storage: Long-term storage in liquid nitrogen tanks, with an annual storage fee.

Interpretation of Test Indicators: AMH, FSH, and Antral Follicle Count

When evaluating the feasibility of fertility preservation, doctors mainly refer to the following indicators:

• AMH: >1.2 ng/ml is ideal, 0.5-1.0 ng/ml is borderline, and below 0.5 ng/ml indicates poor ovarian response with limited freezing utility.
• FSH: <8 IU/L is ideal, 8-12 IU/L is borderline, and >15 IU/L suggests severely diminished ovarian reserve.
• Antral Follicle Count (AFC): >8 is ideal, 5-8 is borderline, and <5 indicates low response.
• E2: Interpreted in conjunction with FSH to assess follicular development status.

Note: AMH is the most stable indicator for assessing ovarian reserve, but FSH and AFC need to be evaluated in combination with age.

Practitioner's Observation: Most Easily Overlooked Details

Having worked in reproductive medicine for many years, I have found that the following details are often overlooked but directly affect preservation outcomes:

• Laboratory Data Transparency: When choosing a facility, do not just look at the price. Check the laboratory's MII oocyte rate, vitrification survival rate, and recovery rate. These data directly reflect laboratory quality.
• Completeness of Legal Documents: If choosing embryo freezing, it is essential to clarify "how the embryos will be handled if I am unable to use them." It is recommended to have a local lawyer review the legal documents.
• Long-Distance Transport Risk: If you plan to transport eggs or embryos back to your home country in the future, confirm in advance whether the destination country allows import, and whether the logistics for liquid nitrogen tank transport are professional with real-time temperature monitoring.
• Genetic Counseling: For women over 35 or those at risk of genetic diseases, it is recommended to complete chromosome testing before preservation to enable PGT during subsequent use.

Risk Reminder

Fertility preservation does not guarantee future pregnancy 100%. The following risks should be clearly understood:

• The cumulative live birth rate from oocyte cryopreservation is directly related to the number of eggs frozen. It is recommended to freeze at least 15-20 mature oocytes for women under 35, and possibly more for women over 40.
• Laws may change over time. It is advisable to obtain written legal advice before preservation and stay updated on legal developments in Georgia.
• Long-distance transport carries a risk of sample damage. Choose a facility with experience in international logistics and purchase transport insurance.
• The ovarian stimulation process carries a risk of Ovarian Hyperstimulation Syndrome (OHSS). Although the incidence is low, close monitoring under a doctor's guidance is necessary.

It is recommended to complete a formal consultation before making a decision and to obtain written legal advice and laboratory data reports. Fertility preservation is a long-term plan; the earlier you act, the better the results.